Mr Mrs Miss Ms Dr Other


Partner & Patent Attorney

London Office Oxford Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 794 706 5907
Email. [email protected]


From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunology-related therapeutics, RNA therapeutics, synthetic biology and genetic diagnostics, including applications of bioinformatics. This continues as a partner of both the specialist HGF CRISPR and microbiome IP teams.

Claire has extensive experience of opposition and appeal proceedings at the European Patent Office, including both defending and opposing high profile patents which have attracted much interest beyond patent professionals. This has included patents from the early days of recombinant antibodies through to controversial patents arising from gene discovery and more recently, much publicised patents for gene-editing technologies.

Claire also has much experience of handling patent portfolios demanding inter-disciplinary input including in the fields of bioinformatics and medical and diagnostic devices. This has included much in the application of high-throughput nucleic acid sequencing technologies such as non-invasive foetal testing and cancer diagnostics.

As one of the most experienced patent partners’ of the life science team, Claire has the reputation of being able to apply creative thinking to turn around the most difficult IP problems. She has been responsible for building the IP portfolios of a number of companies and continues to enjoy the challenge of advising on freedom-to-operate and IP strategy.


Patent Attorney

Chartered (UK)


MA(Oxon) Biochemistry with supplemental chemical pharmacology


PhD St George's Hospital Medical School


IAM Patent 1000 listed in 2021

Accompanying quotes: a " fearless warrior"; "Claire pays meticulous attention to detail and has superb technical and scientific knowledge; clients can concentrate on their own growth knowing their IP is in safe hands."

View recognition online


Navigating the CRISPR IP confusion

View publication online

IAM Patent 1000 2022

View publication online

Getting your first filing right

View publication online

WIPR Publication 10 April 2019: Life Sciences: it pays to be wary over CRISPR

View publication online

LSIPR article June 2019: Russian Scientist pledges to make more CRISPR- edited babies

View publication online

LSIPR article March 2020: Broad Institute down (but not out) in the European Fight over CRISPR IP

View publication online

Regular provider of WIPR webinars on the CRISPR IP saga

Conferences: 2022

November 29th 2022

LSPN Europe 2022


Event details

May 10th 2022

The HGF IP in Healthcare Conference 2022


Event details

March 23rd 2022

HGF webinar: Getting your first filing right


Event details

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020


Event details

Conferences: 2019

November 21st 2019

Life Sciences Patent Network Europe 2019


Event details

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel


Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia


Event details

April 25th 2019

Life Science Patent Network North America - Boston


Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester


Event details

Related News

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article

Profiting from Innovation Within Product Platforms

Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …

Read article
Event - 25th May 2023

New seminar series in Salzburg, Dresden and Hamburg

HGF is organising a new German-speaking seminar series in Salzburg, Dresden, and Hamburg starting May 25 2023. Dates May 25, 2023 at 17:30 – Salzburg June 1 2023 at 17:30 …

Event details

Can Artificial Intelligence save the NHS?

In recent months, it has been almost impossible to escape reports of the staffing crisis in the NHS and the impact this is having on the services the NHS can …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.